Back to School: How biopharma can reboot drug development. Access exclusive analysis here

SGP exercises option for VPHM's pleconaril

Schering-Plough (SGP) exercised its 2003 option to license an intranasal formulation

Read the full 115 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE